| Judith Nepveu, Md, MD | |
|
201 Congress St., Morrisville, VT 05661-0126 | |
| (802) 888-5626 | |
| Not Available |
| Full Name | Judith Nepveu, Md |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 201 Congress St., Morrisville, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366532061 | NPI | - | NPPES |
| 00004323 | Other | VT | BCBS |
| 1039021 | Other | VT | CIGNA |
| 20V105 | Other | VT | MVP |
| 260052162 | Other | VT | RAILROAD MEDICARE |
| 0004323 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 042-0002544 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judith Nepveu, Md, MD P.o.b. 126, Morrisville, VT 05661-0126 Ph: (802) 888-5626 | Judith Nepveu, Md, MD 201 Congress St., Morrisville, VT 05661-0126 Ph: (802) 888-5626 |
News Archive
In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance therapy after transplant can improve outcomes.
A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation.
New structures of a botulism toxin interacting with a mimic of the nerve-cell protein it destroys suggest new ways to block this often-fatal interaction. Indeed, the mimic molecules have such high affinity for the toxin and bind to it so tightly that they themselves could possibly serve as anti-toxin drugs with further modification, the researchers said.
Telormedix, a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases, today announced the start of a Phase I/II clinical study of TMX-101 for the treatment of Non-Muscle Invasive Bladder Cancer. TMX-101 is an immunotherapeutic compound and Telormedix has already recruited the first patients for this clinical study.
› Verified 5 days ago
Jean M Prunty, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-5688 Fax: 802-888-6818 | |
Dr. Linda Susan Zamvil, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 607 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-8320 Fax: 802-888-8136 | |
Victoria Russell, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Box 520, 1986 Lower Elmore Mountain Road Box 520, Morrisville, VT 05661 Phone: 802-888-5955 |